Meghan Drayton Jackson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Meghan Drayton Jackson has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Amy L. Dunn
Nationwide Children’s Hospital, Division of Pediatric Hematology, Oncology and Bone Marrow Transplant
2 shared publications A. Balofsky
Department of Anesthesiology, University of Rochester Medical Center, Rochester, NY, USA
1 shared publication- Alana Barbato
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA
1 shared publication Amy L. Dunn
Division of Hematology, Oncology, and BMT, Nationwide Children's Hospital
1 shared publication- Asif Iqbal
Department of Anesthesiology, University of Rochester Medical Center, Rochester, NY, USA
1 shared publication - Blair Welch
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA
1 shared publication
Latest Publications
- 23 October 2026
- Published by Wiley in Pediatric Blood & Cancer
- p. e70774
Empowering Home Pain Management in Sickle Cell Disease: Standardizing EMR‐Based Outpatient Action Plans
Objective: Sickle cell disease (SCD) causes unpredictable vaso‐occlusive pain episodes, requiring effective outpatient pain management. Historically, outpatient pain plans were primarily paper‐based and rarely documented in the electronic medical record (EMR), limiting provider access and confirmation that a plan existed. This quality improvement (QI) initiative aimed to increase the distribution and documentation of outpatient pain action plans (OPAPs) from 0% to 75% in six months and maintain it for one year. Secondary aims included improving home pain management satisfaction and reducing emergency department (ED) visits. Methods: Using QI methodology, a multidisciplinary team identified barriers, including EMR limitations, clinic workflow, printer availability, and language accessibility. Previously, no documented pain plans were found on chart review. A key driver diagram guided multiple Plan–Do–Study–Act (PDSA) cycles to develop an EMR‐integrated OPAP and a standardized workflow for creation, updating, and distribution. Eligible patients included English‐speaking individuals with SCD older than 6 months, who were not followed by the chronic pain clinic. An up‐to‐date OPAP was defined as those completed within the past 12 months. QI Macros and statistical process control charts were used for analysis. Results: Between September 16, 2021, and July 6, 2023, up‐to‐date OPAP documentation increased from 0% to 59%. Audited sustainability data demonstrated continued improvement, reaching 84% in 2024. Admissions through the ED or infusion room remained unchanged. Of surveyed families, 85% (22/26) rated the pain plan 5/5 stars, highlighting its value in guiding medication scheduling and alternative pain relief interventions. Conclusions: Standardizing EMR‐based OPAPs improved documentation and accessibility for providers. Family satisfaction with home pain management during the post‐intervention periods was high. Future efforts include refining templates, expanding language accessibility, and strengthening transitions between inpatient and outpatient pain plans.
- 23 October 2026
- Published by Wiley in Pediatric Blood & Cancer
- p. e70774
Empowering Home Pain Management in Sickle Cell Disease: Standardizing EMR‐Based Outpatient Action Plans
Objective: Sickle cell disease (SCD) causes unpredictable vaso‐occlusive pain episodes, requiring effective outpatient pain management. Historically, outpatient pain plans were primarily paper‐based and rarely documented in the electronic medical record (EMR), limiting provider access and confirmation that a plan existed. This quality improvement (QI) initiative aimed to increase the distribution and documentation of outpatient pain action plans (OPAPs) from 0% to 75% in six months and maintain it for one year. Secondary aims included improving home pain management satisfaction and reducing emergency department (ED) visits. Methods: Using QI methodology, a multidisciplinary team identified barriers, including EMR limitations, clinic workflow, printer availability, and language accessibility. Previously, no documented pain plans were found on chart review. A key driver diagram guided multiple Plan–Do–Study–Act (PDSA) cycles to develop an EMR‐integrated OPAP and a standardized workflow for creation, updating, and distribution. Eligible patients included English‐speaking individuals with SCD older than 6 months, who were not followed by the chronic pain clinic. An up‐to‐date OPAP was defined as those completed within the past 12 months. QI Macros and statistical process control charts were used for analysis. Results: Between September 16, 2021, and July 6, 2023, up‐to‐date OPAP documentation increased from 0% to 59%. Audited sustainability data demonstrated continued improvement, reaching 84% in 2024. Admissions through the ED or infusion room remained unchanged. Of surveyed families, 85% (22/26) rated the pain plan 5/5 stars, highlighting its value in guiding medication scheduling and alternative pain relief interventions. Conclusions: Standardizing EMR‐based OPAPs improved documentation and accessibility for providers. Family satisfaction with home pain management during the post‐intervention periods was high. Future efforts include refining templates, expanding language accessibility, and strengthening transitions between inpatient and outpatient pain plans.
- 28 August 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (1) , 149-156
Decreasing early invasive mechanical ventilation exposure in preterm infants: a quality improvement initiative
- 28 August 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (1) , 149-156
Decreasing early invasive mechanical ventilation exposure in preterm infants: a quality improvement initiative
- 1 July 2019
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 41 (5) , e284-e289
Inpatient Health Care Utilization in Children With Hemophilia Before and After the Joint Outcome Study Publication
The “Joint Outcomes Study” (JOS) demonstrated improved joint outcomes for patients receiving primary prophylaxis versus on-demand therapy. The impact of primary prophylaxis on inpatient health care utilization is not well-defined. To evaluate changes in hospitalization care of children with hemophilia before and after the 2007 JOS publication, this study utilized the Pediatric Health Information System (PHIS) to evaluate admissions for patients with hemophilia A or B (age, 2 to 7) admitted between January 2002 and 2006 (pre-JOS) and January 2010 and 2014 (post-JOS). Discharge diagnosis codes and clinical transaction classifications were used to differentiate bleeding episodes, infections, bypass agent use, length of stay, and intensive care unit (ICU) management. Overall, admissions for bleeding episodes did not change (26.5% of admissions pre-JOS vs. 23.6% post-JOS, P=0.10). However, admissions for suspected infections increased (3.0% of admissions pre-JOS vs. 7.2% post-JOS, PP<0.01). The necessity for ICU care in children with hemophilia has decreased since publication of the JOS. However, expanded adoption of primary prophylaxis is associated with more hospitalizations for suspected systemic infections, likely due to utilization of central venous catheters to deliver clotting factor concentrates.
- 1 July 2019
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 41 (5) , e284-e289
Inpatient Health Care Utilization in Children With Hemophilia Before and After the Joint Outcome Study Publication
The “Joint Outcomes Study” (JOS) demonstrated improved joint outcomes for patients receiving primary prophylaxis versus on-demand therapy. The impact of primary prophylaxis on inpatient health care utilization is not well-defined. To evaluate changes in hospitalization care of children with hemophilia before and after the 2007 JOS publication, this study utilized the Pediatric Health Information System (PHIS) to evaluate admissions for patients with hemophilia A or B (age, 2 to 7) admitted between January 2002 and 2006 (pre-JOS) and January 2010 and 2014 (post-JOS). Discharge diagnosis codes and clinical transaction classifications were used to differentiate bleeding episodes, infections, bypass agent use, length of stay, and intensive care unit (ICU) management. Overall, admissions for bleeding episodes did not change (26.5% of admissions pre-JOS vs. 23.6% post-JOS, P=0.10). However, admissions for suspected infections increased (3.0% of admissions pre-JOS vs. 7.2% post-JOS, PP<0.01). The necessity for ICU care in children with hemophilia has decreased since publication of the JOS. However, expanded adoption of primary prophylaxis is associated with more hospitalizations for suspected systemic infections, likely due to utilization of central venous catheters to deliver clotting factor concentrates.
- 29 May 2019
- Published by Wiley in Haemophilia
- Vol. 25 (4) , 626-632
Optimizing patient flow in a multidisciplinary haemophilia clinic using quality improvement methodology
Introduction: Multidisciplinary clinics in academic settings are often inefficient and can lead to lengthy clinic visits for patients and staff.Aim: We aimed to use quality improvement (QI) methodology and a multidisciplinary approach to optimize outpatient comprehensive haemophilia clinic flow.Methods: At baseline, a multidisciplinary QI team created a key driver diagram to identify drivers of haemophilia clinic flow. Identified drivers included patient needs/scheduling, provider flow and laboratory/research requirements. From December 2016 to August 2017, value stream mapping (VSM) was used to identify barriers to clinic flow, and plan–do–study–act cycles were used to address these barriers. Interventions included (a) standardizing the order in which providers saw patients to enable time‐sensitive laboratories, (b) improving HTC team meeting functionality, (c) optimizing a visual management board and implementing a flow coordinator, (d) initiating a team huddle prior to clinic start and (e) modifying the clinic appointment template. Timely laboratory draw was used as a surrogate marker of clinic flow, and VSM utilization percentage was used as an objective measure of efficiency.Results: We did not demonstrate a statistically significant improvement in timed laboratory draws; however, clinic utilization percentage increased by 30%, which resulted in adding point‐of‐care musculoskeletal ultrasound services without lengthening clinic duration.Conclusion: Quality improvement methodology is an effective means of improving clinic utilization in a multidisciplinary clinic.
- 29 May 2019
- Published by Wiley in Haemophilia
- Vol. 25 (4) , 626-632
Optimizing patient flow in a multidisciplinary haemophilia clinic using quality improvement methodology
Introduction: Multidisciplinary clinics in academic settings are often inefficient and can lead to lengthy clinic visits for patients and staff.Aim: We aimed to use quality improvement (QI) methodology and a multidisciplinary approach to optimize outpatient comprehensive haemophilia clinic flow.Methods: At baseline, a multidisciplinary QI team created a key driver diagram to identify drivers of haemophilia clinic flow. Identified drivers included patient needs/scheduling, provider flow and laboratory/research requirements. From December 2016 to August 2017, value stream mapping (VSM) was used to identify barriers to clinic flow, and plan–do–study–act cycles were used to address these barriers. Interventions included (a) standardizing the order in which providers saw patients to enable time‐sensitive laboratories, (b) improving HTC team meeting functionality, (c) optimizing a visual management board and implementing a flow coordinator, (d) initiating a team huddle prior to clinic start and (e) modifying the clinic appointment template. Timely laboratory draw was used as a surrogate marker of clinic flow, and VSM utilization percentage was used as an objective measure of efficiency.Results: We did not demonstrate a statistically significant improvement in timed laboratory draws; however, clinic utilization percentage increased by 30%, which resulted in adding point‐of‐care musculoskeletal ultrasound services without lengthening clinic duration.Conclusion: Quality improvement methodology is an effective means of improving clinic utilization in a multidisciplinary clinic.
- 12 February 2019
- Published by Wiley in Haemophilia
- Vol. 25 (2) , 258-263
Increasing optimal coagulation factor dosing in the paediatric emergency department: A quality improvement study
Introduction: Haemophilia is a disorder complicated by bleeding episodes that require emergent medical evaluation. Factor replacement dosing can present challenges for emergency department (ED) care.Aims: We aimed to reduce out‐of‐range factor dosing in the ED. Specifically, we sought to increase the number of haemophilia ED patient visits between encounters where sub‐optimal factor dosing was administered from a baseline of 4‐15 encounters.Methods: A chart review was completed on all patients with haemophilia A (HA) or B (HB) seen in the ED for injuries requiring factor concentrate from September 2015 to August 2016. Injuries were classified as minor—requiring a 50% factor correction or major—requiring a 100% factor correction. Optimal dosing range was defined as 90%‐120% of the institutional guideline goal for the degree of injury. The predicted optimal dose range for each patient was compared to the actual dose administered.Results: Baseline data demonstrated optimal dosing range in 70% of encounters. There was no difference between patients with HA or HB in frequency of out‐of‐range dosing (P = 0.15). There was no difference in frequency of out‐of‐range dosing between types of clotting factor concentrate used. After initiation of quality improvement (QI) interventions, we achieved 16 encounters between out‐of‐range dosing, exceeding our goal of 15. However, this success was not sustained.Conclusion: Optimal coagulation factor dosing is important for patient care and resource management. QI interventions promoted increased accuracy of factor dosing for patients with haemophilia seen in the ED.
- 12 February 2019
- Published by Wiley in Haemophilia
- Vol. 25 (2) , 258-263
Increasing optimal coagulation factor dosing in the paediatric emergency department: A quality improvement study
Introduction: Haemophilia is a disorder complicated by bleeding episodes that require emergent medical evaluation. Factor replacement dosing can present challenges for emergency department (ED) care.Aims: We aimed to reduce out‐of‐range factor dosing in the ED. Specifically, we sought to increase the number of haemophilia ED patient visits between encounters where sub‐optimal factor dosing was administered from a baseline of 4‐15 encounters.Methods: A chart review was completed on all patients with haemophilia A (HA) or B (HB) seen in the ED for injuries requiring factor concentrate from September 2015 to August 2016. Injuries were classified as minor—requiring a 50% factor correction or major—requiring a 100% factor correction. Optimal dosing range was defined as 90%‐120% of the institutional guideline goal for the degree of injury. The predicted optimal dose range for each patient was compared to the actual dose administered.Results: Baseline data demonstrated optimal dosing range in 70% of encounters. There was no difference between patients with HA or HB in frequency of out‐of‐range dosing (P = 0.15). There was no difference in frequency of out‐of‐range dosing between types of clotting factor concentrate used. After initiation of quality improvement (QI) interventions, we achieved 16 encounters between out‐of‐range dosing, exceeding our goal of 15. However, this success was not sustained.Conclusion: Optimal coagulation factor dosing is important for patient care and resource management. QI interventions promoted increased accuracy of factor dosing for patients with haemophilia seen in the ED.
- 1 May 2017
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 30, 16-22
Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study
- 1 May 2017
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 30, 16-22
Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study